When company insiders buy or sell stock in their own companies, the transactions may or may not offer a hint about a company’s prospect. Legendary investment manager Peter Lynch once remarked that insiders sell shares for any number of reasons, but they only buy more stock for one reason: they think the price will go up.
There wasn’t a lot of insider buying last week, but there was one transaction worth noting. Salesforce.com chairman and CEO Marc Benioff exercised an option to acquire 20,000 shares at a price of $59.34 per share. The transaction occurred on July 23 and the company’s stock closed that day at $248.25.
In the coming week, seven companies are expected to price initial public offerings (IPOs) and another two are listed as day-to-day. Here’s the full list (the last two are day-to-day). The market cap is based on expected pricing at the midpoint of the IPO price range.
|Company||Ticker||Price Range||Deal Size||Market cap|
|Better Being Co.||(BBCO)||$15.00 – $17.00||$200 million||$843.4 million|
|Cadre Holdings||(CDRE)||$16.00 – $19.00||$125 million||$606 million|
|European Wax Center||(EWCZ)||$15.00 – $18.00||$175 million||$1.05 billion|
|Orange County Bancorp||(OBT)||$32.00 – $35.00||$30 million||$30.2 million|
|WCG Clinical||(WCGC)||$14.00 – $16.00||$720 million||$6.1 billion|
|Weber||(WEBR)||$15.00 – $17.00||$750 million||$5.6 billion|
|Healthcare Royalty||(HCRX)||$15.00 – $17.00||$750 million||$3.45 billion|
|Context Therapeutics||(CNTX)||$12.00 – $14.00||$20 million||$19.5 million|
|ROX Financial||(ROXA)||$10.00||$83 million||$89.5 million|
After a company submits its first filing for an IPO, company executives typically embark on a “roadshow,” meeting with big investors and brokerages to tout the virtues of both their company and the stock. Once the stock begins trading, however, the company and its staff enter what’s known as a quiet period during which they may not talk about the company or its stock. The quiet period lasts 40 days.
Special-purpose acquisition companies, aka SPACs or blank-check companies, that combine with a start-up to come public in a reverse merger play by different rules. The U.S. Securities and Exchange Commission (SEC) treats these deals as mergers, not IPOs, and often there is no quiet period at all.
Most investment banks that underwrite IPOs do not issue research, including projections, on the company for a period of 25 days. This is done by custom more than by regulation, but the SEC and the courts appear to be satisfied with the length of the underwriters’ quiet period. When these reports are finally made public, they usually reinforce all the reasons the underwriter chose to participate in the IPO in the first place.
A similar restriction applies to company employees (insiders) who may be prohibited from selling any shares they may own for a period of time, generally between 90 and 180 days. For SPACs, the lockup period typically lasts between 180 days and a full year. A lockup period is not mandated by SEC rules, but are set by the company in its IPO registration and is intended to keep insiders from flooding the market with shares and, in so doing, eroding the share price.
For the week ending August 6, nine companies will see their 25-day underwriter research quiet period end and another nine will see the insider lockup periods expire.
Here are the nine companies with lockup expirations coming this week.
|Evaxion Biotech A/S||(EVAX)||Biopharma|
|Lucira Health||(LHDX)||Medical Devices|
Here are the nine companies for which the underwriter’s quiet period expires this week.
|Moving iMage Technologies||(MITQ)||Electronics|
|TELUS International||(TIXT)||Enterprise IT|
ALSO READ: Electric Vehicle Buying Surge May Be Huge for Power Companies: 5 Top Dividend Stocks to Buy
Get Our Free Investment Newsletter
Source: Read Full Article